Pharming Group N.V. (PHAR) Inventory (2019 - 2024)

Pharming (PHAR) has disclosed Inventory for 6 consecutive years, with $55.7 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Inventory fell 1.87% year-over-year to $55.7 million, compared with a TTM value of $55.7 million through Dec 2024, down 1.87%, and an annual FY2024 reading of $55.7 million, down 1.87% over the prior year.
  • Inventory was $55.7 million for Q4 2024 at Pharming, down from $56.8 million in the prior quarter.
  • Across five years, Inventory topped out at $56.8 million in Q4 2023 and bottomed at -$2.4 million in Q4 2021.
  • Average Inventory over 5 years is $25.7 million, with a median of $20.5 million recorded in 2020.
  • The sharpest move saw Inventory plummeted 111.94% in 2021, then skyrocketed 2979.76% in 2023.
  • Year by year, Inventory stood at $20.5 million in 2020, then tumbled by 111.94% to -$2.4 million in 2021, then rose by 19.49% to -$2.0 million in 2022, then surged by 2979.76% to $56.8 million in 2023, then decreased by 1.87% to $55.7 million in 2024.
  • Business Quant data shows Inventory for PHAR at $55.7 million in Q4 2024, $56.8 million in Q4 2023, and -$2.0 million in Q4 2022.